Starsource Multitrade

Starsource Multitrade ROE

The Return on Equity (ROE) of Starsource Multitrade (506365.BO) as of Oct 27, 2026 is -919.24 %. In the previous year, Return on Equity (ROE) was 2.60 % — a change of -35,399.55% (lower).

ROE

-919.24 %

YoY

-35,399.55%

Last updated:

In 2026, Starsource Multitrade's return on equity (ROE) was -919.24 %, a -35,399.55% increase from the 2.60 % ROE in the previous year.

The Starsource Multitrade ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
2.00 INR
Jan 1, 2020
3.86 INR
Jan 1, 2021
2.27 INR
Jan 1, 2022
4.85 INR
Jan 1, 2023
0.41 INR
Jan 1, 2024
9.38 INR
Jan 1, 2025
2.60 INR
Jan 1, 2026
-919.24 INR
The Starsource Multitrade ROE history
YEARROEYoY
-919.24 %-35,399.55%
2.60 %-72.23%
9.38 %+2,199.68%
0.41 %-91.59%
4.85 %+113.06%
2.27 %-41.13%
3.86 %+93.47%
2.00 %+100.91%
0.99 %-97.87%
46.74 %-218.48%
-39.44 %-821.75%
5.47 %+9.91%
4.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

ROE Details

Decoding Starsource Multitrade's Return on Equity (ROE)

Starsource Multitrade's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Starsource Multitrade's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Starsource Multitrade's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Starsource Multitrade’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Starsource Multitrade stock

Return on Equity (ROE) of Starsource Multitrade is -919.24 % in 2026.

Return on Equity (ROE) of Starsource Multitrade changed from 2.60 % to -919.24 %, representing a -35,399.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Starsource Multitrade with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Starsource Multitrade

All Key Metrics — Starsource Multitrade